4//SEC Filing
Pizzie Nick 4
Accession 0001209191-22-017158
CIK 0001579428other
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:02 PM ET
Size
8.4 KB
Accession
0001209191-22-017158
Insider Transaction Report
Form 4
Pizzie Nick
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-03-04+41,176→ 41,176 total→ Common Stock (41,176 underlying) - Award
Employee Stock Option (Right to Buy)
2022-03-04+77,872→ 77,872 totalExercise: $29.91Exp: 2032-03-03→ Common Stock (77,872 underlying)
Footnotes (3)
- [F1]The option will vest in substantially equal quarterly installments over four years such that the option will be fully vested on March 4, 2026.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the RSUs will vest on the one (1) year anniversary of the date of grant. The remaining RSUs will vest in in three substantially equal annual installments, such that the RSUs will be fully vested on March 4, 2026. Vested shares will be delivered to the reporting person upon the earlier of (i) the closing of a Change in Control (as defined in the Issuer's Amended and Restated 2015 Omnibus Incentive Compensation Plan (the "Plan"), (ii) the reporting person's separation of service from the Issuer (including termination with or without Cause (as defined in the Plan), or termination due to death or disability), or (iii) seven (7) years from the date of grant.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001742143
Filing Metadata
- Form type
- 4
- Filed
- Mar 7, 7:00 PM ET
- Accepted
- Mar 8, 5:02 PM ET
- Size
- 8.4 KB